Anti-PD1 (RetifanlimAb biosimilar) monoclonal Antibody
Retifanlimab (Zynyz), is an anti-cancer drug used for the treatment of Mercel cell Carcinoma. Retifanlimab is a Programmed death Receptor 1 (PD-1) blocking Monoclonal antobody. Retifanlimab blocks the interaction between PD-1 and its ligands PD-L1/2, and it acts as an immune checkpoint modulator.
Product Specifications
Product Name Alternative
Zynyz
Host
Humanized
Reactivity
Human
Target Antigen
PD-1
Applications
FACS
Components
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Storage Conditions
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing) . Lyophilized antibodies are shipped at ambient temperature.
Applications Notes
FACS 1:100
Isotype
IgG4 (P108S)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680029-100 1x 100 µL
Fibronectin (TV-1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470266-500 1x 500 µL
Human IgG Immunoglobulin (IG266), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400181-100 1x 100 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940040-100 1x 100 µL
CD35 / CR1 (E11), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682416-500 1x 500 µL
CD5 (Mantle Cell Lymphoma Marker) (CD5/2416), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401014-100 1x 100 µL
ACTH (Adrenocorticotrophic Hormone) (2F6), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details